12 LHRH analogues in the management of uterine fibroids, premenstrual syndrome and breast malignancies
- 1 September 1988
- journal article
- review article
- Published by Elsevier in Bailliere's Clinical Obstetrics and Gynaecology
- Vol. 2 (3) , 689-709
- https://doi.org/10.1016/s0950-3552(88)80053-1
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- THE USE OF AN LHRH AGONIST, BUSERELIN, IN THE LONG-TERM MANAGEMENT OF PREMENSTRUAL SYNDROMESClinical Endocrinology, 1987
- Long-acting gonadotropin hormone-releasing hormone analogused to treat uteriFertility and Sterility, 1986
- Premenstrual Complaints. I. Prevalence of Premenstrual Symptoms in a Swedish Urban PopulationJournal of Psychosomatic Obstetrics & Gynecology, 1986
- Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cellsEuropean Journal of Cancer and Clinical Oncology, 1985
- Ovulation inhibition with nafarelin acetate nasal administration for six monthsContraception, 1985
- Steroid Secretion in Polycystic Ovarian Disease after Ovarian Suppression by a Long-Acting Gonadotropin-Releasing Hormone Agonist*Journal of Clinical Endocrinology & Metabolism, 1983
- Uterine leiomyomata: etiology, symptomatology, and managementFertility and Sterility, 1981
- Combination Chemotherapy as an Adjuvant Treatment in Operable Breast CancerNew England Journal of Medicine, 1976
- Ultrasound Diagnosis of Gynecologic Pelvic MassesRadiology, 1974
- THE TECHNIQUE AND RESULTS OF MYOMECTOMY.The Lancet, 1931